Evotec Ag is a German biotech company that has financed much of its proprietary research by engaging in drug discovery and development for other biotech companies in a strategy that looks like it will pay off.
Research into biomarkers for Alzheimer’s disease has shown that plasma is a potentially rich source of these indicators, according to an investigator from King’s College London.
The world’s largest developer of candidate vaccines for acquired immune deficiency syndrome (AIDS) plans to set up a new fund to locate and develop new ideas relating to vaccines. Details were to be announced by the end of June.